The Lens Newsletter: July 2, 2025

Too busy to read the Lens? Listen to our weekly summary here! In this week's episode we discuss...

• Certain systemic medications for T2DM may increase DME risk, while others are protective, suggesting medication choice impacts retinal health.

• Daily low-dose valacyclovir reduces herpes zoster ophthalmicus-related recurrence at 18 months, supporting utility in long-term suppression.

• RVO incidence rose during the COVID-19 pandemic in South Korea among middle-aged adults, while RAO rates remained stable. 

• Nanopore sequencing shows promise for uveitis diagnosis, detecting herpes viruses with up to 75% sensitivity and 100% specificity.